Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background Thoracentesis and thoracoscopy are used to diagnose malignant pleural
effusions (MPE). Data on how sensitivity varies with tumour type is limited. Methods …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

Background Lung cancer is usually suspected in individuals who have an abnormal chest
radiograph or have symptoms caused by either local or systemic effects of the tumor. The …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Background: Diagnostic yield (DY) and safety of computed tomography (CT)-and thoracic
ultrasound (TUS)-guided biopsies in the diagnosis of pleural lesions have been investigated …

The detection of neoplastic invasion remains the linchpin for a clear diagnosis of malignant
mesothelioma. Cytology-only diagnosis of epithelioid mesothelioma on aspirated effusion …

Although during the last few years there have been several important changes in the
diagnostic or therapeutic methods, pleural effusion is still one of the diseases that the …

Introduction: Pleural effusion is a common clinical problem. Yet, in a significant proportion of
patients (~ 20%), the cause of pleural effusion remains unknown. Understanding the …

Abstract Malignant Pleural Mesothelioma (MPM) remains a relevant public health issue, and
asbestos exposure is the most relevant risk factor. The incidence has considerably and …